silver investing Zacatecas Silver Signs Option to Acquire the Lourdes Gold-Silver Project from Guanajuato Silver
silver investing Zacatecas Silver Expands Oso Negro to Over 3 Kilometres of Mapped Gold-Silver Veins; Phase Two Rock Chip Sampling Returns up to 20.3 g/t Gold and 3,480 g/t Silver
silver investing Zacatecas Silver Announces Non-Brokered Private Placement of up to $2,500,000 to Advance Oso Negro Drill Program
silver investing Zacatecas Silver Announces 21% Increase in High-Grade Heap-Leach Updated Gold Mineral Resource at the Esperanza Gold Project to 1.15 Moz AuEq from 45.4 Mt at 0.79 g/t - Grades Above Global Heap-Leach Average & Highest Grades at Surface
silver investing Zacatecas Silver Completes 2,027 Metre Diamond Drilling Program at El Cristo, Intersecting Multiphase Silver-Base Metal Veins Across 19 Holes - Assays Pending
silver investing Zacatecas Silver Reports High-Grade Gold and Silver Surface Sampling Over 2 km Strike Length at Oso Negro, Sonora
silver investing Zacatecas Silver Enters into Definitive Option Agreement to Acquire Multi-Asset Exploration Portfolio from Heliostar Metals
silver investing Zacatecas Silver Completes Surface Sampling and Mapping Program at Oso Negro Project, Sonora, Mexico
silver investing Zacatecas Silver Announces Drilling Commencement and Completion of First Hole at El Cristo
GoldInxs Mining Corp. Closes Second Tranche of Upsized Non-Brokered Private Placement and Announces Board Changes
RENFORTH INTERSECTS BROAD NICKEL-COBALT AND ZINC-COPPER-SILVER MINERALIZATION IN VICTORIA UNDERCUT DRILLING, INCLUDING 118.0 m OF 0.081% Ni AND 10.9 m OF 0.544% Zn
CoTec Holdings Corp. Notes HyProMag USA Deployment of Mobile Inserma System, Extending Hard Disk Drive Processing to Customer Sites Across the United States
Renforth Successfully Intersects Gold in Both Drillholes Undercutting Surface Gold Results within the 2025 MRE Pit Shell at Wholly Owned Parbec Gold Deposit in Malartic, Quebec
Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site
